Cibc World Market Inc. Affimed N.V. Transaction History

Cibc World Market Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 08, 2019	SELL	$2.6 - $4.21 $172,900 - $279,965	-66,500 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$3.05 - $4.34 $30,500 - $43,400	10,000 Added 17.7%	66,500 $279,000
Q4 2018 Feb 13, 2019	BUY	$2.82 - $4.67 $91,650 - $151,775	32,500 Added 135.42%	56,500 $176,000
Q3 2018 Nov 09, 2018	BUY	$1.45 - $6.15 $34,800 - $147,600	24,000 New	24,000 $104,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.